Exploring How Durvalumab Immunotherapy Targets Cancer Cells
Durvalumab, known commercially as Imfinzi, is revolutionizing cancer treatment through its innovative approach as an immunotherapy drug. By targeting the PD-L1 protein, it empowers the immune system to effectively combat cancer cells. As research progresses, understanding its mechanisms, applications, and potential side effects becomes essential for optimizing patient outcomes in various cancer types. Understanding Durvalumab […]
3 minute read